Trinity Biotech PLC ADR | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
91,278.10
103,276.80
99,655.80
99,322.30
100,164.50
96,930.60
Cost of Goods Sold (COGS) incl. D&A
47,930.60
56,039.40
56,298.40
58,928.70
61,178.70
58,348.10
Gross Income
43,347.50
47,237.40
43,357.40
40,393.60
38,985.70
38,582.40
SG&A Expense
34,725.60
29,890.30
30,268.20
31,066.70
36,639.70
33,234.20
EBIT
8,621.90
17,347.10
13,089.20
3,800.00
2,346.00
5,348.20
Unusual Expense
843.60
-
12,936.00
41,507.30
38,103.70
23,910.20
Non Operating Income/Expense
1,171.80
349.60
149.20
172.50
615.30
256.70
Interest Expense
-
-
3,894.90
5,357.40
4,730.40
5,074.50
Pretax Income
10,227.00
17,792.20
22,752.90
42,017.90
40,287.00
23,158
Income Tax
574.40
840.00
1,074.20
3,546.70
1,226.50
524.40
Consolidated Net Income
9,652.60
16,952.20
21,678.70
38,471.20
39,060.50
22,633.60
Net Income
9,652.60
16,952.20
21,678.70
38,471.20
39,060.50
22,633.60
Net Income After Extraordinaries
9,652.60
16,952.20
21,678.70
23,391.00
37,434.90
23,201
Net Income Available to Common
9,652.60
16,952.20
21,678.70
100,333.40
40,686.10
22,066.20
Basic Shares Outstanding
21,936.60
22,749.70
23,161.80
22,964.70
21,621.60
20,903.20
EPS (Diluted)
0.41
0.71
0.46
3.44
1.88
1.06
Diluted Shares Outstanding
23,428.20
23,717.70
27,407.80
28,299.40
21,621.60
20,903.20
EBITDA
12,214.30
21,773.70
18,700.80
9,612.10
7,598.70
9,464.80
Other Operating Expense
-
-
-
5,526.90
-
-
Non-Operating Interest Income
1,276.90
95.50
473.40
874.50
816.30
735.20
About Trinity Biotech
View Profile
